Search results
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via AOL· 5 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
FDA clears GSK's RSV vaccine for adults ages 50-59
UPI· 4 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 5 days agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 13 hours agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
Zacks via Yahoo Finance· 16 hours agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 13 hours agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agovaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 7 days agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 3 days agoGSK GSK announced that the FDA has approved the expanded use of its respiratory syncytial virus...